Content area

|
|

Optimering af thiopurinbehandling ved kronisk inflammatorisk tarmsygdom

Forfatter(e)
Marianne Kiszka-Kanowitz, Klaus Theede & Anette Mertz Nielsen Gastroenheden, Medicinsk Sektion, Hvidovre Hospital Ugeskr Læger 2014;176:V01140019
Reference: 
Ugeskr Læger 2014;176:V01140019
Blad nummer: 
Sidetal: 
1253-1255
Optimized thiopurine treatment in chronic inflammatory bowel disease
Thiopurines are effective in maintaining remission in chronic inflammatory bowel diseases, but incomplete response or side effects are common during standard-dose treatment. In this article thiopurine metabolism and pharmacogenetic aspects are summarized showing their benefits in improving therapy in chronic inflammatory bowel disease. An increasing body of evidence suggests that a large part of the observed non-pancreatic side effects and poor responses can be solved by tailoring thiopurine therapy using measurement of thiopurine methyltransferase and metabolites and by using a combination therapy with low-dose thiopurines and allopurinol.
Du skal være logget ind for at læse denne artikel
Log ind

Right side